APA (7th ed.) Citation

Saravolatz, L. D., Stein, G. E., & Johnson, L. B. (2009). Telavancin: A Novel Lipoglycopeptide. Clinical infectious diseases, 49(12), 1908-1914. https://doi.org/10.1086/648438

Chicago Style (17th ed.) Citation

Saravolatz, Louis D., Gary E. Stein, and Leonard B. Johnson. "Telavancin: A Novel Lipoglycopeptide." Clinical Infectious Diseases 49, no. 12 (2009): 1908-1914. https://doi.org/10.1086/648438.

MLA (9th ed.) Citation

Saravolatz, Louis D., et al. "Telavancin: A Novel Lipoglycopeptide." Clinical Infectious Diseases, vol. 49, no. 12, 2009, pp. 1908-1914, https://doi.org/10.1086/648438.